文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

危重症患者围插管期主要不良事件的发生率:系统评价与Meta分析

Prevalence of peri-intubation major adverse events among critically ill patients: A systematic review and meta analysis.
PubMed 文献 · Am J Emerg Med · 2023-06-28
一句话结论手术室外插管约1/3发生围插管期主要不良事件,ICU(41%)高于急诊科(17%),血流动力学不稳定者风险最高,作者认为复苏应视为所有插管的组成部分。

该系统评价与Meta分析检索PubMed、Scopus和Embase,纳入44篇文章、34,357次手术室外或麻醉后恢复室外插管,主要结局为任何围插管期主要不良事件(低氧、低血压/心血管崩溃或心脏骤停)。围插管期主要不良事件发生率为30.5%(95%CI 25-37%),ICU为41%(95%CI 33-49%)、急诊科为17%(95%CI 12-24%),低氧15%(95%CI 11.5-19%)、心脏骤停2%(95%CI 1-3.5%)、心血管崩溃18%(95%CI 13-23%)。因血流动力学不稳定插管与主要不良事件发生率更高相关,因气道保护插管与更低相关。作者认为复苏应视为所有插管的组成部分,尤其高危患者。

要点

  • 手术室外插管围插管期主要不良事件总体发生率30.5%(95%CI 25-37%),约每3例插管有1例发生。
  • ICU插管主要不良事件发生率41%(95%CI 33-49%),高于急诊科的17%(95%CI 12-24%)。
  • 因血流动力学不稳定插管与主要不良事件发生率更高相关,因气道保护插管与更低相关。
  • 低氧发生率15%(95%CI 11.5-19%),心血管崩溃18%(95%CI 13-23%),心脏骤停2%(95%CI 1-3.5%)。
  • 作者认为复苏应视为所有插管的组成部分,尤其高危患者。

适用人群与场景

  • 在急诊科、重症监护病房或内科病房插管的危重症患者;纳入报告手术室外或麻醉后恢复室外插管围插管期主要不良事件的前瞻性和回顾性观察性研究及随机对照试验。

诊断标准与关键阈值

  • 围插管期主要不良事件定义为任何低氧、低血压/心血管崩溃或心脏骤停;食管插管和首次插管未成功不计为主要不良事件。

处置流程与药物剂量

  • 作者认为复苏应视为所有插管的组成部分,尤其高危患者。

红旗征与不能漏的情况

  • 因血流动力学不稳定插管与主要不良事件发生率更高相关。

研究设计与关键结果

  • 系统评价与Meta分析纳入44篇文章、34,357次插管;围插管期主要不良事件发生率为30.5%(95%CI 25-37%)。
  • ICU插管主要不良事件发生率41%(95%CI 33-49%),急诊科为17%(95%CI 12-24%)。
  • 低氧发生率15%(95%CI 11.5-19%),心脏骤停2%(95%CI 1-3.5%),心血管崩溃18%(95%CI 13-23%)。
  • 因血流动力学不稳定插管与主要不良事件发生率更高相关,因气道保护插管与更低相关。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入前瞻性和回顾性观察性研究及随机对照试验;使用Cochrane Risk of Bias 2工具和Newcastle-Ottawa量表评估研究质量。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对手术室外插管的危重症患者,应预判围插管期主要不良事件风险,ICU插管及因血流动力学不稳定插管者风险最高。
  • 作者认为复苏应视为所有插管的组成部分,尤其高危患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Peri-intubation major adverse events (MAEs) are potentially preventable and associated with poor patient outcomes. Critically ill patients intubated in Emergency Departments, Intensive Care Units or medical wards are at particularly high risk for MAEs. Understanding the prevalence and risk factors for MAEs can help physicians anticipate and prepare for the physiologically difficult airway.

METHODS: We searched PubMed, Scopus, and Embase for prospective and retrospective observational studies and randomized control trials (RCTs) reporting peri-intubation MAEs in intubations occurring outside the operating room (OR) or post-anesthesia care unit (PACU). Our primary outcome was any peri-intubation MAE, defined as any hypoxia, hypotension/cardiovascular collapse, or cardiac arrest. Esophageal intubation and failure to achieve first-pass success were not considered MAEs. Secondary outcomes were prevalence of hypoxia, cardiac arrest, and cardiovascular collapse. We performed random-effects meta-analysis to identify the prevalence of each outcome and moderator analyses and meta-regressions to identify risk factors. We assessed studies' quality using the Cochrane Risk of Bias 2 tool and the Newcastle-Ottawa Scale.

RESULTS: We included 44 articles and 34,357 intubations. Peri-intubation MAEs were identified in 30.5% of intubations (95% CI 25-37%). MAEs were more common in the intensive care unit (ICU; 41%, 95% CI 33-49%) than the Emergency Department (ED; 17%, 95% CI 12-24%). Intubation for hemodynamic instability was associated with higher rates of MAEs, while intubation for airway protection was associated with lower rates of MAEs. Fifteen percent (15%, 95% CI 11.5-19%) of intubations were complicated by hypoxia, 2% (95% CI 1-3.5%) by cardiac arrest, and 18% (95% CI 13-23%) by cardiovascular collapse.

CONCLUSIONS: Almost one in three patients intubated outside the OR and PACU experience a peri-intubation MAE. Patients intubated in the ICU and those with pre-existing hemodynamic compromise are at highest risk. Resuscitation should be considered an integral part of all intubations, particularly in high-risk patients.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Downing J, Yardi I, Ren C, et al. Prevalence of peri-intubation major adverse events among critically ill patients: A systematic review and meta analysis. Am J Emerg Med. 2023. PMID: 37437438. doi:10.1016/j.ajem.2023.06.046

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。